back
Steve Mansberger
Academic titles
Senior Scientist
Profession
Glaucoma Specialist
Organization
Devers Eye Institute
Fields of Interest
Clinical Care;Detection;Drug Delivery;Medical Treatment;Public Health;Surgery
Steve Mansberger at WGC-2023
Thursday 29 June 2023 16:45-17:45 CEST Room C
Is It Better Not to Know? (practical genetics)
Chair(s): Alon Harris (United States); Steven S. Mansberger (United States);
- Genetic testing for glaucoma care is an inevitability
David Mackey (Australia) - Genetic testing - might it be better not to know?
Inas Aboobakar (United States) - MRI scanning in NTG
Helen Danesh-Meyer (New Zealand) - Sleep studies
Samantha Lee (Australia) - 24 hour IOP monitoring
Kevin Gillman (Switzerland) - Testing of the more central visual field
Aaki Shukla (United States)
Friday 30 June 2023 10:30-12:00 CEST Room B
Risk Factors Debate
Chair(s): Arthur Sit (United States); Thasarat Vajaranant (United States); Ningli Wang (China);
- Diabetes IS a Risk Factor
Steven S. Mansberger (United States) - Diabetes is NOT a risk factor
Sasan Moghimi (United States) - Myopia IS a risk factor
Ching-Yu Cheng (Singapore) - Myopia is NOT a risk factor
Parul Ichhpujani (India) - Central Corneal Thickness IS a risk factor
Jamie Brandt (United States) - Central Corneal Thickness IS NOT a risk factor
Anthony Khawaja (United Kingdom)
Saturday 01 July 2023 08:30-10:00 CEST Auditorium
How to (re)organize Glaucoma Treatment Strategies?
Chair(s): Andrew Tatham (United Kingdom); Lisandro Massanori Sakata (Brazil); Omnia Hamam (United Arab Emirates);
- Trabecular MIGS Pro-active treatment evidences: who (really) needs it?
Jella An (United States) - Too much of a good thing: are we over-treating?
- Are laser treatments our best shot? Efficacy, how to monitor it and when to go for re-treatment
Gus Gazzard (United Kingdom) - Topical Glaucoma Treatment: the good and the bad
Miriam Kolko (Denmark) - Sustained drug delivery systems: do they make a difference?
Philiph Phatudi (South Africa) - First step is the best step - what's the best first line option for OHT, early glaucoma, advanced glaucoma
Steven S. Mansberger (United States) - What are the current recommended treatment options for progressing advanced glaucoma?
Florent Aptel (France) - Glaucoma treatment armamentarium: What remains to be investigated in future trials?
Robert Weinreb (United States)